₹ 1,865.20
46.20 (2.54%)
E
Evonile Pharma
₹ 1,865.20
EVONILE Financials Summary
Evonile Pharma revenue decreased 43.34% quarter-on-quarter to ₹64 Cr in Sep 2026, while net profit swung to a loss of ₹78 Cr from a profit of ₹32 Cr in the previous quarter. Compared to the same quarter last year, revenue is down 36.01% and net profit swung to a loss of ₹78 Cr from a profit of ₹24 Cr a year ago. EPS for the quarter stood at -₹31.41, decreased from ₹13.05 in the previous quarter and down from ₹9.81 a year ago.
Evonile Pharma Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of EVONILE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
EVONILE Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






